Skip to main content

Tagungsband zum XVIII. GTFCh–Symposium, 18.-20.04.2013 in Mosbach

Titelblatt

Neue Methoden und neue Wirkstoffe - Auswirkungen auf die Forensische Chemie und Toxikologie

New Trechniques and New Drugs - Impact on Forensic Chemistry and Toxicology


Toxichem Krimtech
Jahrgang 37 · Band 80 · Special Issue · Seiten 215-390 (2013)

ISBN 978-3-00-043163-0

 

 

Inhaltsverzeichnis
Seite
Realität des Alkohol- und Drogenkonsumenten aus Sicht der Rechtsprechung: Die Unterbringung in der Entziehungsanstalt nach §64 StGB und die Zuru?ckstellung der Strafvollstreckung nach §35 BtMG – Allgemeine Grundlagen
Bernd Weidig
215
LC-MS/MS of GHB in head hair and beard
Yvonne Hari, Stefan König, Alexandra Schröck, Patrizia Coro, Volker Auwärter, Annette Thierauf, Wolfgang Weinmann
224
Comprehensive systematic toxicological analysis of human body fluids by parallel LC/MS/MS and GC/MS analysis
Florian Pitterl, Sebastian Köb, Johanna Pitterle, Birthe Schubert, Kathrin Libiseller, Herbert Oberacher
228
Designerdrug 5-IT – a fatal case and analytical profiles of 5-IT and AMT
Jan Schäper, Folker Westphal, Susanna Fehn
231
A fatal case involving several synthetic cannabinoids
Nadine Schaefer, Benjamin Peters, Dietmar Bregel, Stefan Kneisel, Volker Auwärter, Peter H. Schmidt, Andreas H. Ewald
248
Postmortem blood and tissue concentrations of R- and S-enantiomers of methadone and its metabolite EDDP
Ricarda Jantos, Gisela Skopp
252
Practical considerations for reliable quantification in postmortem specimens
Birgit Reiter, Kurt Jiran, Thomas Stimpfl
260
A convenient method for Salvia divinorum analysis and attempt to explain different effects based on the origin
Victoria Spencer, Esra Ergin, Heike Wollersen, Nico Erdmann
262
Can we obtain information from urine about recent cannabis consumption in DUID cases?
Sarah Hangartner, Franz Dussy, Thomas Briellmann
266
Disaccharidnachweis im Urin: geeignete Markersubstanzen fu?r den intravenösen Substitutkonsum?
Hilke Jungen, Hilke Andresen- Streichert, Alexander Mueller, Stefanie Iwersen- Bergmann
270
Combined analysis of synthetic cannabinoids and other designer drugs
Marek Dziadosz, Jens-Peter Weller, Michael Klintschar, Jörg Teske
275
Fast, simple, and validated LC-HR-MS/MS assay for identification and quantification of drugs in human blood plasma often requested in context of brain death diagnosis
Markus R. Meyer, Andreas G. Helfer, Hans H. Maurer
276
Methoxetamine: Metabolism and detectability of a novel ketamine analog – studied by GC-MS, LC-MSn, and LC-HR-MSn
Markus R. Meyer, Martina Bach, Michael Bovens, Alain Turcant, Hans H. Maurer
277
Studies on the metabolism and detectability of the phenethylamine-derived designer drug 2C-P in rat and human urine using GC-MS, LC-MSn, and LC-HR-MS/MS
Markus R. Meyer, Tina Braun, Carina Wink, Alain Turcant, Hans H. Maurer
278
Studies on the metabolism and the detectability of 4-methyl-amphetamine and its isomers 2-methyl-amphetamine, and 3-methyl-amphetamine in rat urine using GC-MS, LC-MSn, and LC-HR-MSn
Jessica Welter, Markus R. Meyer, Pierce Kavanagh, Hans H. Maurer
279
APAAN – a new precursor substance for the illicit production of amphetamine
Lars Müller, Nathalie Martin, Thorsten Rößler, Michael Pütz
280
Forensic trace and comparative analysis related to clandestine amphetamine laboratories
Michael Pütz, Nathalie Martin, Nina Boxen, Jan Rittgen, Thorsten Rößler, Sabine Schneiders
281
Development of an LC-MS/MS approach for screening and identification of benzodiazepines, z-drugs, antidepressants, neuroleptics, PDE-5 inhibitors, opioids and new synthetic drugs in human hair and urine samples
Deborah Montenarh, Markus Hopf, Stefan Warth, Hans H. Maurer, Peter Schmidt, Andreas H. Ewald
282
Metabolism and toxicological detection of the new pyrrolidinophenone designer drug 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP) in rat and human urine using GC-MS and LC-MSn
Markus R. Meyer, Sandra Mauer, Julia Dinger, Golo M. J. Meyer, Birgit Klein, Folker Westphal, Hans H. Maurer
283
Determination of warfare agents (nerve agents, blister agents, saxitoxin and ricin) in food, water and on materials and articles
Martin Weber, Holger Schulz
284
Verification of chemical warfare agent exposure in human samples
Paul W. Elsinghorst, Horst Thiermann, Marianne Koller
288
Trapping 'Spice': a comprehensive, automated LC-ion trap-MS screening approach for the detection of currently 38 synthetic cannabinoids in serum
Laura M. Huppertz, Stefan Kneisel, Volker Auwärter, Jürgen Kempf
293
Ein automatisiertes MSn-basiertes Screening Verfahren fu?r die klinische und forensische Toxikologie
Laura M. Huppertz, Susanne Vogt, Jürgen Kempf
299
Extensive automation of the SPE-GC/MS analysis of opiates, cocaine, their metabolites and methadone from serum and other matrices
Oliver Temme, Oliver Lerch, Gernot Brauers, Thomas Daldrup
304
N-Pentylindole: A marker for the detection of synthetic cannabinoids
Johannes Zagermann, Hellmut Mahler, Bauke H. Albada, Evelyn Pawlik
308
Ethanol concentrations in breath and blood of drunk drivers; results from hand-held breathalyzer devices vs. analysis of venous blood samples
Pirkko Kriikku, Lars Wilhelm, Stefan Jenckel, Janne Rintatalo, Jukka Hurme, Jan Kramer
312
Validation of an alcohol dehydrogenase method for forensic blood alcohol determination on Thermo Scientific Indiko analyzer and comparison with Technikon autoanalyzer
Marcel Grapp, Herbert Desel, Wolfgang Grellner
315
Alternative determination of BAC by means of 1H-NMR
Bernd W. Diehl, Elina Zailer
320
Quantification of the biogenic phenethylamine alkaloid hordenine by LC-MS/MS in beer
Gernot Brauers, Irina Steiner, Thomas Daldrup
323
A preliminary investigation on the influence of flavonoids on ethyl glucuronide formation
Nicole Schwab, Gisela Skopp
327
Analysis of morphine and codeine in dried blood on a carpet – a case report
Julia Krüger, Inge Herrle, Matthias Graw, Hans Sachs, Gabriele Roider
332
Three unusual cases of CO poisoning with each two victims
Heike Wollersen, Freidoon Erdmann, Reinhard B. Dettmeyer, Kayleigh Hennemann, Victoria Spencer
335
Abuse of pregabalin – results of the postmortem toxicology from 2010 to 2012
Stefanie Lottner-Nau, Birgit Övgu?er, Liane D. Paul, Matthias Graw, Hans Sachs, Gabriele Roider
339
Fatality after intake of methylone, MDMA and amphetamine: a case report
Andreas Bauer, Jutta Schöpfer, Hans Sachs, Matthias Graw, Gabriele Roider
343
Entdeckung zweier Leichname nach tödlicher Intoxikation durch orale Applikation von transdermalen Fentanylpflastern
Susanne Vogt, Volker Auwärter, Annette Thierauf
346
Regular cannabis users in road traffic – a result of insufficient monitoring?!
Elke Below, Britta Bockholdt, Giovanni Talarico
349
From palm to hair: transmissibility of methadone and its metabolite EDDP
Kerstin Boomgaarden-Brandes, Niels Tobias, John Koc, Hans Sachs, Bernd Mu?hlbauer
354
Influence of hair straightening on ethyl glucuronide content in hair
Luc Kirchen, Michel Yegles
357
Detection of illicit drugs in meconium to assess neonatal abstinence syndrome (NAS)
Volker Dangel, Rudolf Alkier, Manfred Möller
359
LC/MS/MS method of 6-MAM, morphine, morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G) for quantitative analysis in serum
Susanne Lott, Frank Musshoff, Burkhard Madea
363
Quality control charts for internal quality control of forensic blood alcohol analysis
Georg Schmitt, Gisela Skopp
 367
Auswertung von Ringversuchsdaten: Horwitz vs. DIN ISO 13528
Michael Herbold, Georg Schmitt, Gisela Skopp
 371
A pragmatic approach to detect SPICE metabolites in urine with HPLC-MS/MS
Lars Kröner, Victoria C. Spencer
375
Studies on the metabolism and detectability of xylazine in rat and human urine using
Pharmacokinetics of GHB and detection window in serum and urine after single uptake of a low dose of GBL
Golo M.J. Meyer, Markus R. Meyer, Hans H. Maurer
381
Pharmacokinetics of GHB and detection window in serum and urine after single uptake of a low dose of GBL
Alexandra Schröck, Yvonne Hari, Stefan König, Thomas Wu?thrich, Volker Auwärter, Annette Thierauf, Wolfgang Weinmann
382
Autorenverzeichnis 383
Sachwortverzeichnis 385